Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Methods Enzymol ; 583: 119-141, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28063488

RESUMO

The Ca2+-independent phospholipases A2 (iPLA2s) are part of a diverse family of PLA2s, manifest activity in the absence of Ca2+, are ubiquitous, and participate in a variety of biological processes. Among the iPLA2s, the cytosolic iPLA2ß has received considerable attention and ongoing studies from various laboratories suggest that dysregulation of iPLA2ß can have a profound impact on the onset and/or progression of many diseases (e.g., cardiovascular, neurological, metabolic, autoimmune). Therefore, appropriate approaches are warranted to gain a better understanding of the role of iPLA2ß in vivo and its contribution to pathophysiology. Given that iPLA2ß is very labile, its basal expression is low in a number of cell systems, and that crystal structure of iPLA2ß is not yet available, careful and efficient protocols are needed to appropriately assess iPLA2ß biochemistry, dynamics, and membrane association. Here, step-by-step details are provided to (a) measure iPLA2ß-specific activity in cell lines or tissue preparations (using a simple radiolabel-based assay) and assess the impact of stimuli and inhibitors on resting- and disease-state iPLA2ß activity, (b) purify the iPLA2ß to near homogeneity (via sequential chromatography) from cell line or tissue preparations, enabling concentration of the enzyme for subsequent analyses (e.g., proteomics), and (c) employ hydrogen/deuterium exchange mass spectrometry analyses to probe both the structure of iPLA2ß and dynamics of its association with the membranes, substrates, and inhibitors.


Assuntos
Ensaios Enzimáticos , Fosfolipases A2 do Grupo VI/metabolismo , Animais , Ácidos Araquidônicos/farmacologia , Química Encefálica , Cálcio/metabolismo , Radioisótopos de Carbono , Linhagem Celular , Medição da Troca de Deutério , Fosfolipases A2 do Grupo VI/antagonistas & inibidores , Fosfolipases A2 do Grupo VI/isolamento & purificação , Humanos , Cetonas/farmacologia , Camundongos , Músculo Esquelético/química , Miocárdio/química , Organofosfonatos/farmacologia , Éteres Fosfolipídicos/metabolismo , Espectrometria de Massas por Ionização por Electrospray
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...